Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: ATUX ISKAY GROUP LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-02-15 to 2025-02-14
Current total value of award: $355000
Description: SBIR CONCEPT AWARD - THERAPEUTICS - SULFONYL-UREA AND SULFONAMIDE PP2A ACTIVATORS AS MYCN AMPLIFIED NEUROBLASTOMA (NBL) THERAPEUTICS